Abstract
The outcome after treatment for glioblastoma remains poor. Therefore, the authors evaluated the long term efficacy and toxicity of treatment with radiotherapy and concurrent carboplatin plus teniposide followed by three cycles of carmustine in patients who underwent resection for glioblastoma. Fifty-six newly diagnosed patients with glioblastoma underwent radiotherapy (1.8-2 gray [Gy]/day, 5 days a week using limited fields up to 60 Gy), and concurrent chemotherapy with carboplatin (350 mg/m2) on Days 1, 22, and 43, and teniposide (50 mg/m2) on Days 1, 2, 3, 22, 23, 24, 43, 44, and 45. Four weeks after the end of radiotherapy, patients were given carmustine (200 mg/m2) every 8 weeks for 3 cycles. Treatment then was suspended, but if disease progression was found, treatment was resumed using different drugs. All 56 patients were evaluated for time to progression (TTP) and median survival time (MST). The TTP was 7.5 months and the MST was 12.5 months. Toxicity manifested as thrombocytopenia and in most cases was acceptable. Four patients (7.1%) had radiation necrosis at 2, 2, 7, and 9 months, respectively, from the end of radiotherapy. The results obtained in the current study with concurrent radiochemotherapy in patients with gl...Continue Reading
References
Jul 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B JeremicL Mijatovic
Feb 1, 1992·Journal of Neuro-oncology·W K YungL G Feun
May 11, 1992·Journal of Neurosurgery·W R ShapiroM S Mahaley
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
May 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W K YungM J Gleason
Aug 1, 1991·Journal of Neuro-oncology·F DozM L Rosenblum
Feb 1, 1990·International Journal of Radiation Oncology, Biology, Physics·V A LevinC B Wilson
May 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E E Vokes, R R Weichselbaum
Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Jun 1, 1989·International Journal of Radiation Oncology, Biology, Physics·K E WallnerM G Malkin
Jan 1, 1989·Seminars in Surgical Oncology·T J Dougherty
Jun 1, 1989·Neurology·L M DeAngelisJ B Posner
Jan 1, 1988·Journal of Neuro-oncology·R W WalkerJ B Posner
Apr 1, 1987·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·O F LangeW Scheef
Sep 1, 1980·International Journal of Radiation Oncology, Biology, Physics·G E ShelineV Smith
Jan 1, 1994·Journal of Neuro-oncology·B F Kimler
Aug 1, 1995·Annals of Neurology·K PetersonC L Truwit
Sep 30, 1995·International Journal of Radiation Oncology, Biology, Physics·V A LevinL Rodriguez
Jan 1, 1994·Journal of Neuro-oncology·M G MalkinW R Shapiro
Aug 1, 1994·Neurology·J HildebrandD Afra
Jul 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R P DinapoliJ A Maier
Jan 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S C ScholdD D Bigner
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J GlantzM J Egorin
Citations
Mar 30, 2004·Reproduction : the Official Journal of the Society for the Study of Fertility·Tong SunZeng-Ming Yang
Dec 22, 1999·Biochemical and Biophysical Research Communications·X Z DingT E Adrian
Nov 19, 2013·Pharmaceutical Patent Analyst·Jessica K NorbergEmmanuelle J Meuillet
Jan 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M BredelJ A Hainfellner
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y CaoS M Prescott
Feb 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Siva Kumar KolluriXiao-kun Zhang
Jul 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi NishiharaLars Eckmann
Jan 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Dingzhi Wang, Raymond N DuBois
Apr 11, 2008·Neuro-oncology·Alba A BrandesEnrico Franceschi
Nov 22, 2011·Contemporary Clinical Trials·Edward WhiteSteven Gill
Jun 19, 2004·Pathology·Mehar SharmaChitra Sarkar
Jun 30, 2009·Brain Research·Yiming LiHongyu Yu
Jan 5, 2002·Hematology/oncology Clinics of North America·E J Dropcho
Apr 7, 2016·European Radiology·Ra Gyoung YoonJeong Hoon Kim
Oct 21, 2016·Oncoimmunology·Nathan B RobertsGraeme F Woodworth
May 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alba A BrandesMario Ermani
Aug 31, 1999·The Annals of Pharmacotherapy·H B NewtonL K McCoy
Oct 3, 2001·CNS Drugs·M T Jennings, S Iyengar
Apr 28, 2005·Expert Review of Neurotherapeutics·Carsten NiederMichael Molls
Aug 23, 2018·Journal of Neuro-oncology·Nathan B RobertsGraeme F Woodworth
Oct 20, 2006·Journal of Neuro-oncology·Lynn G FeunNiramol Savaraj
Feb 20, 2003·British Journal of Cancer·B Fazeny-DörnerC Marosi
Apr 6, 2012·Journal of Neuro-oncology·Edward WhiteSteven Gill
Apr 16, 2014·Journal of Neuro-oncology·Daniel J BratUNKNOWN AANS/CNS Joint Guidelines Committee
Oct 19, 1999·Oncogene·N ShinouraH Hamada
Jun 11, 2003·American Journal of Clinical Oncology·P BeauchesneT Schmitt
Mar 11, 2020·Oncology Reviews·Ehsan AlimohammadiAlireza Abdi